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Abstract: Background: The healing potential of platelet growth factors has generated interest in using Platelet-Rich 
Plasma (PRP) in ridge preservation procedures. A canine study was performed to determine if extraction sites treated with 
platelet-rich fibrin matrix (PRFM) exhibit enhanced healing compared to sites treated with non-viable materials.  
Methods: Four dog’s extraction sockets were treated individually with PRFM, PRFM and membrane, Demineralized 
Freeze-Dried Bone Allograft (DFDBA) and membrane, PRFM and DFDBA, and untreated control. Treatment sequencing 
permitted clinical and histologic evaluation of healing at 10 days, 2, 3, 6 and 12 weeks.  
Results: Healing was more rapid in the PRFM and PRFM and membrane sites. By 3 weeks those sockets had osseous fill. 
Sites containing DFDBA had little new bone at 6 weeks. By 12 weeks those sockets had osseous fill but DFDBA particles 
were still noted in coronal areas. 
Conclusions: PRFM alone may be the best graft for ridge preservation procedures. Advantages: faster healing, and elimi-
nation of disadvantages involved in using barrier membranes. 
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INTRODUCTION  
  Guided Bone Regeneration (GBR) procedures, employ-
ing non-vital bone grafting materials and membranes were 
developed to counteract the significant resorption of alveolar 
bone following tooth extraction [1-3]. Although ridge di-
mensions were improved with these procedures, the amount 
of augmention created at the time of GBR was not the 
amount of augmented bone present after several months of 
healing [4, 5]. The loss of augmentation is probably related, 
in part, to the lack of vascularity and viability of commer-
cially prepared graft materials. 
  According to many investigators a better choice for re-
generative procedures are autogenous bone grafts obtained 
from intraoral and extraoral sites [6, 7]. Extraoral grafts, 
such as the iliac crest marrow grafts, have excellent os-
teogenic potential but have the disadvantages of a second 
surgical site, with possible site morbidity, and reports of 
rapid resorption when used intra-orally [8]. Graft materials 
from intraoral sites also have potential site morbidity, sig-
nificant resorption, and a limited graft volume that can be 
harvested [9]. Intraoral block grafts cells have a limited vital-
ity, (24 hours), before the osteocytes undergo necrosis [10]. 
Autogenous particulate grafts from cancellous bone have   
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relatively few cells and those obtained from cortical bone are 
almost devoid of cells. 
  Autogenous grafts that do contain vital tissue are those 
obtained from the centrifugation of a patient’s whole blood. 
In the late 1970’s, early 1980’s Hunt and Neighlton [11] 
described the separation of patient’s blood by centrifugation 
into three layers; 1) platelet-rich plasma (PRP), 2) platelet-
poor plasma and 3) red and white blood cell layers. It is the 
PRP layer that is of interest for use in wound healing since 
this layer contains a concentrate of the patient’s plate-
lets.These platelets have granules that contain growth factors 
that affect every cell and the formation of every tissue in-
volved in the wound healing and regeneration of soft tissue 
and bone (Table 1). Marx et al. [12] first described the use of 
PRP in dental surgery. They claimed a radiographic matura-
tion rate of bone grafts with PRP that was 1.62 to 2.16 times 
more rapid than grafts without PRP.  
  In the preparation methods of PRP described by Marx  
et al. [12] and others, the coagulation process to obtain a gel 
was initiated with 10% calcium chloride and bovine throm-
bin. The introduction of an endogenous initiator of coagula-
tion (usually bovine thrombin) in most of the commercially 
available methods of PRP preparation has the effect of caus-
ing rapid degranulation of platelets and almost immediate 
liberation of growth factors into the surgical area at the time 
of preparation [13]. Since growth factors have a limited time 
of effectiveness, immediate release of growth factors can 
only affect the immediate stages of wound healing and not Clinical and Histological Comparison of Extraction Socket Healing  The Open Dentistry Journal, 2009, Volume 3    93 
the extended period of time needed for bone and soft tissue 
regeneration.  
   A platelet-rich fibrin material, which does not use bo-
vine thrombin as an activator, has been described as a Plate-
let-Rich Fibrin Matrix (PRFM).
* The proprietary process for 
PRFM preparation separates the blood cells from the plate-
lets and plasma proteins, during an initial low speed cen-
trifugation of a patient’s blood. A second centrifugation con-
verts fibrinogen to fibrin in the presence of CaCl2 and the 
fibrin cross-links to form a matrix that contains viable plate-
lets. Carroll et al. [14] have demonstrated, in vitro, that the 
viable platelets in PRFM released 6 growth factors in about 
the same concentration for the 7-day duration of their study.  
  Given prolonged growth factor presence it would be ex-
pected that PRFM treatment of an extraction socket might 
result in enhanced wound healing compared to those sites 
treated with non-viable graft materials. To test this hypothe-
sis, a study was designed to compare PRFM*, to conven-
tional GBR techniques utilizing demineralized freeze dried 
bone allograft (DFDBA) and bioresorbable collagen mem-
brane, in a histologic study in dogs. 
MATERIALS AND METHODS 
  The study was conducted on four mongrel dogs weighing 
20 - 25kg. The experimental protocol was approved by the 
Institutional Animal Care and Use Committee of the Univer-
sity of Medicine and Dentistry of New Jersey. Four treatment 
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PRFM alone 2) PRFM with an osseous graft (DFDBA) incor-
porated 3) PRFM covered by a resorbable collagen membrane 
and 4) DFDBA covered by a resorbable collagen membrane.
** 
In each dog, all of these modalities were individually em-
ployed in extraction sites immediately after tooth extraction. 
One site in each animal was included as an untreated control. 
   In order to assess extraction site healing over time, the 
times of extraction were staggered. The sequencing was de-
signed so that each dog had the same seven teeth extracted in 
2 surgeries. The timing of the surgeries in each dog captured 
the healing at 2 time specific intervals. The design also per-
mitted each treatment modality and each time interval to be 
present in two different animals. Healing was evaluated at 10 
days, 2 weeks, 3 weeks, 6 weeks and 12 weeks post-opera- 
tively 
PREPARATION OF THE PLATELET RICH FIBRIN 
MATERIAL (PRFM) 
  PRFM was prepared by collecting 9 ml of venous blood 
from each animal in a collection/separation tube (Tube 1) 
prior to beginning the extractions. This tube contained 1) a 
buffered tri-sodium citrate additive that prevents clotting 
during the separation stage and 2) a proprietary separation 
material. Tube 1 was centrifuged for 6 minutes at 1100g 
(RCF). Following centrifugation, PRP comprises the super-
natant above the thixotropic separation gel and the red and 
white blood cell fractions are below the separation material. 
  Just prior to the graft material being placed, the PRP su-
pernatant was transferred into a second tube (Tube 2) via a  
 
__________________________ 
**Bioguide Collagen Membrane, Osteohealth Co., Shirley, N.Y. 
Table 1.  Growth Factors Found in Platelets in PRFM 
Factor  Target Cell/Tissue  Function 
PD-EGF  
(epidermal growth factor) 
•  Blood vessel cells, outer skin cells 
•  Fibroblasts, and many other cell types 
•  Cell growth, recruitment  
•  Differentiation, skin closure 
•  Cytokine secretion 
 PDGF, A+B 
(platelet-derived growth factor) 
•  Fibroblasts, smooth muscle cells, chondrocytes, 
osteoblasts, mesenchymal stem cells 
•  Potent cell growth, recruitment 
•  Blood vessel growth, granulation 
•  Growth factor secretion; matrix formation 
w/BMPs (collagen and bone) 
 TGF-ß1 
(transforming growth factor beta1) 
•  Blood vessel tissue, outer skin cells 
•  Fibroblasts, monocytes 
•  TGF gene family includes the BMPs 
•  Osteoblasts – highest levels of TGF-r 
•  Blood vessel (+/-), collagen syn. 
•  Growth inhibition, apoptosis (cell death) 
•  Differentiation, activation 
 IGF-1,2 
(insulin-like growth factor1,2) 
•  Bone, blood vessel, skin, other tissues 
•  Fibroblasts 
•  Cell growth, differentiation, recruitment  
•  Collagen synthesis w/PDGF 
 VEGF/ECGF 
(vascular endothelial GF) 
•  Blood vessel cells  •  Cell growth, migration, new blood vessel growth 
•  Anti-apoptosis (anti-cell death) 
bFGF 
 (basic fibroblast growth factor) 
•  Blood vessels, smooth muscle, skin 
•  Fibroblasts, other cell types 
•  Cell growth 
•  Cell migration, blood vessel growth 94    The Open Dentistry Journal, 2009, Volume 3  Simon et al. 
male/female Luer-Loc ‘Angel Wing’ transfer device. Tube 2 
contains a calcium chloride additive that facilitates clotting 
of the PRP. Tube 2 was centrifuged for 15 minutes at 1450g 
(RCF). This spin caused the PRP to become a PRFM, which 
is a gel containing a 5x platelet/fibrin concentrate, as com-
pared to the animal’s normal whole blood plus residual se-
rum. The gel was easily divided so that [1] aliquot could be 
used for treatment with the gel alone and the 2
nd aliquot 
mixed with DFDBA as the sequencing of the study design 
required. 
Surgical Procedure 
  Preoperatively, a fentanyl patch was applied on a shaved 
portion of the dogs side and, glycopyrrolate (0.01 mg/kg), 
acepromazine (0.1 mg/kg), and morphine (0.5 mg/kg IV) 
were given as pre-medication. Thiopental (10-20mg/kg) 
given intravenously used for induction of anesthesia with 
isoflurance 1-3% inhaled via an endotracheal tube was used 
for general anesthesia. Local infiltration of lidocaine (2%) 
with epinephrine (1:50,000) was administered for hemostasis 
and to reduce postoperative pain.  
  Sulcular incisions were made around the teeth to be ex-
tracted. Full-thickness buccal and lingual flaps were re-
flected. The roots of the teeth were carefully and atraumati-
cally extracted. Digital photographs were taken pre, during, 
and post surgery.  
  Treatment of each extraction site was performed accord-
ing to the sequencing schedule previously described (Table 
2). Where employed, the membranes were carefully posi-
tioned in accordance with the principles of human GBR pro-
cedures. Flaps were sutured with 4-0 Ethibond™ sutures.
*** 
  Postoperatively the dogs were administered morphine (0.5 
mg/kg) intramuscularly and a Fentanyl patch for analgesia and 
clindamycin (11 mg/kg PO, BID) for 5 days. The dog’s oral 
cavities were rinsed with a solution of 0.12% chlorhexidine 
rinse daily until sacrifice. The animals were weighed once 
weekly for the first two weeks post-operatively. A soft diet 
was provided for about 10 days post-surgery. 
 
__________________________ 
***Ethibond Sutures, Ethicon Surgical, Sommerville, N.J.  
Histologic Preparation 
   Immediately after sacrifice the specimens were placed in 
10% formalin solution. Following fixation, decalcification of 
the block sections was accomplished by immersion in undi-
luted RDO for approximately 5 - 8 days. Dehydration fol-
lowed by paraffin embedding and microtome serial section-
ing (5μ) was performed. Slides were stained with Hematox-
ylin and Eosin, or Mallory’s Trichrome.  
RESULTS 
   Clinically, all of the 28 extraction sockets healed un-
eventfully. Soft tissue healing proceeded normally but ap-
peared to be more rapid in the PRFM alone sites. By the end 
of the 12 weeks of the study all sites were clinically healed 
completely. Histologically, the healing was quite different 
and much more rapid for those sockets treated with PRFM 
alone or with a membrane as compared to those sites in 
which DFDBA was used as a graft. The most important ob-
servations are summarized below.  
PRFM Alone and PRFM and Membrane (Fig. 1) 
1)  10 days - PRFM alone and PRFM and a membrane sock-
ets were filled with an organized connective tissue and 
very little cellular infiltrate. 
2)  2  weeks - complete epithelialization of the wound had 
occurred. A well-organized fibrous connective tissue was 
seen with new bone growing from the entire periphery of 
the socket toward the center of the site. 
3)  3 weeks - the sites were completely filled with new bone. 
DFDBA and Membrane (Fig. 2) 
1)  3 weeks - the specimens have a thin epithelium overlying 
the extraction site with a slight discontinuity. The socket 
was still filled with non-vital DFDBA particles and dense 
inflammatory infiltration. No new bone formation was 
seen in the extraction socket. 
2)  6 weeks - epithelialization of the wound was not com-
plete and non-vital osseous particles appeared to be pre-
sent in the fibrous connective tissue overlying the area. 
The socket contained fibrous connective tissue but non-
vital osseous particles surrounded by an inflammatory in-
Table 2.  Schedule of Extractions 
   1
st Surgery 
2 Week  
Healing 
3 Week  
Healing 
4 Week  
Healing 
6 Week  
Healing 
9 Week  
Healing 
12 Week  
Healing 
Dog  A  Extractions  4      3   
End 
Point 
Dog  B  Extractions  3       4 
End 
Point 




Dog D  Extractions  3  4 
End 
Point 
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filtrate could still be noted. There was a minimal amount 
of new bone observed in the apical third of the socket.  
3)  12 weeks - maxillary sites had complete fill of the socket 
with new bone and only a few bone chips were seen in 
the overlying connective tissue. In mandibular sites 
(above section – omit this reference to an above section), 
new bone filled most of the socket, but in the coronal 
third there was a cone shaped area of non-vital bone par-
ticles, surrounded by inflammatory infiltrate and connec-
tive tissue. This cone was narrow in the center of the 
socket becoming wider in the coronal portion of the area. 
PREM with DFDBA (Fig. 3) 
  Sites treated with PRFM and DFDBA healed slower than 
those with PRFM alone or with a membrane but faster than 
those grafted with DFDBA and a membrane.  
1)  3 weeks – epithelization is complete and some new bone 
is noted in apical areas of the socket. Non-vital osseous 
particles and an inflammatory infiltrate in the connective 
tissue is still the predominate feature.  
2)  6 weeks - new bone is filling the apical half of the socket. 
The coronal portion of the socket still contains non-vital 
bone chips. 
3)  12 weeks - PRFM and DFDBA treated sockets exhibited 
almost the same histologic picture at 12 weeks, as the 
DFDBA and membrane areas except for fewer non-vital 
osseous particles, inflammatory infiltrate and connective 
tissue in the coronal portion of the socket. 
Untreated Control 
  Control ungrafted extraction sites at 6 weeks had virtu-
ally complete osseous fill of the socket. However, there ap-
peared to be significant loss of alveolar height. 
DISCUSSION 
  The advantageous effects of platelet-rich fibrin matrix 
(PRFM), upon healing of extraction sites in dogs, would 
appear to be due to the many proposed benefits of PRP 
growth factors which drive the wound healing processes and 


















Fig. (1). PRFM alone and PRFM and Membrane. 
10 days - PRFM alone and PRFM and a membrane sockets were filled with an organized connective tissue (CT) and very little cellular infil-
trate. 
2 weeks - complete epithelialization (E) of the wound had occurred. A well-organized fibrous connective tissue (CT) was seen with new 
bone growing from the entire periphery of the socket toward the center of the site. 
3 weeks - the sites were completely filled with new bone (B). 
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[15-17], enhanced vascular ingrowth [18,19], enhanced soft 
tissue healing [20, 21], mitogenic effects [22, 23] and in-
creased bone regeneration [17, 24, 25]. 
  Whether the proposed benefits of PRP result in superior 
healing has been investigated in humans and experimental 
animals. Although several reports have suggested that the 
addition of PRP to an osseous graft enhances healing in vari-
ous applications [12, 26-28], other studies have indicated 
that adding PRP to a graft did not enhance the quantity or 
quality of new bone formation [29-33]. However, it is diffi-
cult to compare the animal studies since they used different 
animals, different study designs and platelet yields. The hu-
man studies were also varied in study design, numbers of 
patients, and application. Further, there were differences in 
PRP preparation, which would influence the content and 
concentration of growth factors in the PRP [34].  
   The PRP material used in this study is termed PRFM 
(Platelet-Rich Fibrin Matrix) and it differs from other com-
mercially available PRP systems in that it does not use bo-
vine thrombin or other exogeneos activators in the prepara-
tion process. The PRFM preparation process creates a gel-
like matrix that contains high concentrations of non-
activated, functional, intact platelets, contained within a fi-
brin matrix, that release, a relatively constant concentration 
of growth factors over a period of 7 days [14]. Unless there 
was a precipitous drop in concentration soon thereafter, there 
presumably would be sufficient concentration of these fac-
tors to influence the healing well into the normal sequence of 
introduction and functional maturation of the important heal-
ing elements.  
    The prolonged presence of growth factors in the healing 



















Fig. (2). DFDBA and Membrane. 
3 weeks - the specimens have a thin epithelium (E) overlying the extraction site with a slight discontinuity. The socket was still filled with 
non-vital DFDBA particles (NVB) and dense inflammatory infiltration. No new bone formation was seen in the extraction socket. 
6 weeks - epithelialization (E) of the wound was not complete and non-vital osseous particles appeared to be present in the fibrous connec-
tive tissue overlying the area. The socket contained fibrous connective tissue (CT) but non-vital osseous particles surrounded by an inflam-
matory infiltrate could still be noted. There was a minimal amount of new bone (B) observed in the apical third of the socket.  
12 weeks - maxillary sites had complete fill of the socket with new bone and only a few bone chips were seen in the overlying connective 
tissue. In mandibular sites (above section), new bone (B) filled most of the socket, but in the coronal third there was a cone shaped area of 
non-vital bone particles (NVB), surrounded by inflammatory infiltrate and connective tissue. This cone was narrow in the center of the 
socket becoming wider in the coronal portion of the area. 
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more rapid healing in the extraction sockets grafted with 
PRFM alone noted in this investigation. However, the pro-
longed presence of non-vital DFDBA particles and the ac-
companying inflammatory infiltrate noted during the healing 
through 12- weeks, was undoubtedly also a significant rea-
son for delayed healing in the sockets where that material 
was used. Sites treated with PRFM alone had complete osse-
ous fill of the extraction socket in 3 weeks, while sites 
treated with non-vital DFDBA still did not exhibit complete 
fill after 12 weeks. The fact that these DFDBA particles cre-
ated an inflammatory/ foreign body reaction during healing 
of sockets has been reported in many studies. Becker et al. 
[35, 36] histologically evaluated human osseous graft cores 
and concluded that the over-riding histological characteristic 
of sites grafted with DFDBA or MFDBA was the retention 
of non-vital graft particles encapsulated with fibrous connec-
tive tissue. They suggested that the elimination of the non-
vital bone particles from the wound was accomplished by 
macrophages or giant cells (foreign body reaction) or by 
sequestration, similar to the reactions observed in this inves-
tigation, not by resorption.. They concluded that non-vital 
osseous graft materials would delay healing and affect the 
quality of regenerated bone.  
   There may be other benefits when PRFM is used alone, 
without a membrane, as a graft. 1) Decreased time required 
to perform the socket preservation procedure. In the conven-
tional GBR procedure using a membrane and DFDBA, prop-
erly placing and stabilizing the membrane after placement of 
the graft can take some time. When PRFM alone is used as 
the graft, the time required to place and stabilize the mem-
brane is saved, since the membrane and its stabilization are 
not needed. 2) Elimination of complications and a reduction 



















Fig. (3). PRFM and DFDBA. 
Sites treated with PRFM and DFDBA healed slower than those with PRFM alone or with a membrane but faster than those grafted with 
DFDBA and a membrane.  
3 weeks – epithelization (E) is complete and some new bone (B) is noted in apical areas of the socket. Non-vital osseous particles (NVB) and 
an inflammatory infiltrate in the connective tissue (CT) is still the predominate feature.  
6 weeks - new bone (B) is filling the apical half of the socket. The coronal portion of the socket still contains non-vital bone chips (NVB). 
12 weeks - PRFM and DFDBA treated sockets exhibited the almost the same histologic picture at 12 weeks as the DFDBA and membrane 
areas except for fewer non-vital osseous particles, inflammatory infiltrate and connective tissue in the coronal portion of the socket. 
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Membrane exposure of non-resorbable membranes has been 
shown to virtually eliminate any increase in ridge augmenta-
tion [37, 38]. Exposure of bioresorbable membranes may 
also result in a relative reduction in ridge augmentation, but 
the effects of exposure appear insignificant relative to those 
reported with non-resorbable membranes [5]. Obviously, if a 
membrane is not used or needed during the ridge preserva-
tion procedure, the potential disadvantages of membrane 
exposure are not a consideration. 3) “Better quality” of bone 
in healed extraction sites grafted with PRFM alone, because 
the sites will not contain non-vital bone chips. Non-vital 
DFDBA chips may take years to become resorbed by 
macrophages. Not only will the non-vital graft material delay 
normal bone formation, but the residual chips may weaken 
the host bone and/or create less than optimum bone next to 
dental implants [36]. 4) Possibly less bone resorption and 
therefore more ridge width and height after healing. Lekovic 
et al. [39]  quantified the changes in alveolar width and 
height when a polygalactide/polylactide membrane was used 
for ridge preservation in intact extraction sockets (our Class I 
sockets). They recorded a 1.31 mm (17.79%) mean net loss 
of alveolar width and a 0.38 mm (11.59%) net loss of height 
after 4 to 6 months of healing. A more recent investigation 
by Iasella et al. [40] found that extraction sites treated with 
Demineralized Freeze Dried Bone Allograft (DFDBA) and a 
collagen membrane, incurred a mean net loss of 1.2 mm 
(13.04)% of pre-operative width. Other studies have shown 
an even greater net loss of width and height following GBR 
healing [4, 5]. The documented loss of alveolar height and 
width in these studies may be due to the inflammatory or 
foreign body reaction associated with non-vital bone parti-
cles. The inflammatory or foreign body reaction might cause 
resorption of the internal walls of the socket. In the coronal 
portions of the socket the width of osseous walls are thin, 
and internal resorption might lead to a reduction of the ridge 
after healing. With PRFM alone as the graft material, the 
healing process is more rapid and does not have an associ-
ated foreign body reaction adversely affecting the amount of 
bone formation.  
CONCLUSIONS 
  PRFM may represent a simple and effective means of 
accelerating new bone growth in a variety of oral and dental 
applications without the disadvantages of barrier mem-
branes, non-vital graft materials or exogenous thrombin as-
sociated with other PRP systems. 
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